期刊文献+

P2Y12基因多态性与氯吡格雷抵抗的相关性研究 被引量:3

原文传递
导出
摘要 目的:为临床合理应用氯吡格雷提供参考。方法:检索近年来关于P2Y12基因多态性与氯吡格雷抵抗的相关性研究文献,进行归纳、总结。结果与结论:P2Y12受体C34T、G52T、i-T744c位点的基因多态性是否会影响氯吡格雷的抗血小板治疗效果,诱发氯吡格雷抵抗,并使得患者的主要心血管不良事件的发生风险增加,以及CYP2C19基因多态性的存在是否会与P2Y12基因多态性共同影响氯吡格雷的抗血小板治疗效果,目前的研究尚无统一的定论,还需要更多的前瞻性研究来揭示。
出处 《中国药房》 CAS CSCD 2014年第32期3065-3068,共4页 China Pharmacy
  • 相关文献

参考文献6

二级参考文献73

  • 1郝盼盼,陈玉国,张运.氯吡格雷抵抗相关因素的研究进展[J].心血管病学进展,2009,30(6):991-994. 被引量:21
  • 2华轶男,谢梅林.阿司匹林抵抗机制及防治研究进展[J].中国药理学通报,2006,22(6):655-659. 被引量:5
  • 3FONTANA P, DUPONT A, GANDRILLE S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects [ J ]. Circulation,2003, 108(8):989 -995.
  • 4MEHTA SR, YUSUF S, PETERS RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study[J]. Lancet, 2000, 358(9281):527 -533.
  • 5YUSUF S, ZHAO F, MEHTA SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-elevation[ J ]. N Engl J Med , 2001, 345 (7) :494 -502
  • 6NGUYEN TA, DIODATI JG, PHARAND C. Resistance to clopidogrel : a review of the evidence[ J]. J Am Coll Cardiol, 2005, 45(8) :1157 -1164.
  • 7VON BECKERATH N, VON BECKERATH O, KOCH W, et al. P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose [ J ]. Blood Coagul Fibrinolysis, 2005, 16 ( 3 ) : 199 - 204.
  • 8ANGIOLILLO DJ, FERNANDEZ-ORTIZ A, BERNARDO E, et al. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease[J]. Thromb Res, 2005, 116(6) :491 -497.
  • 9BLIN N, STAFFORD DW. A general method for isolation of high molecular weight DNA from eukaryotes [ J ]. Nucleic Acids Res, 1976, 3(9) :2303 -2308.
  • 10LAU WC, GURBEL PA, WATKINS PB, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J ]. Circulation, 2004, 109 ( 2 ) :166 -171.

共引文献55

同被引文献26

  • 1吴小利,李健,王成彬.氯吡格雷抵抗患者的血小板功能的实验室监测和遗传基因多态性的研究进展[J].临床检验杂志(电子版),2014,3(2):595-602. 被引量:2
  • 2Thuy Anh Nguyen,Jean G. Diodati,Chantal Pharand.Resistance to clopidogrel: A review of the evidence[J]. Journal of the American College of Cardiology . 2005 (8)
  • 3Simon Tabassome,Verstuyft Céline,Mary-Krause Murielle,Quteineh Lina,Drouet Elodie,Méneveau Nicolas,Steg P Gabriel,Ferrières Jean,Danchin Nicolas,Becquemont Laurent.Genetic determinants of response to clopidogrel and cardiovascular events. The New England Quarterly . 2008
  • 4Mega JL,Close SL,Wiviott SD, et al.Genetic variants in ABCB1, CYP2C19, and cardiovascular outcomes following treatment with clopidogrel and prasugrel.. The Lancet . 2010
  • 5Taubert Dirk,von Beckerath Nicolas,Grimberg Gundula,Lazar Andreas,Jung Norma,Goeser Tobias,Kastrati Adnan,Sch?mig Albert,Sch?mig Edgar.Impact of P-glycoprotein on clopidogrel absorption. Clinical Pharmacokinetics . 2006
  • 6Muller I,Besta F,Schulz C,et al.Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thrombosis and Haemostasis . 2003
  • 7Angiolillo,Dominick J.??Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions(J)Diabetes Care . 2009 (4)
  • 8Bonello L,De Labriolle A,Scheinowitz M,et al.Emergence of the concept of platelet reactivity monitoring of response to thienopyridines. Heart . 2009
  • 9Tang K,Ngoi SM,Gwee PC,et al.Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics . 2002
  • 10孙春喜,任澎.基因多态性与阿司匹林和氯吡格雷抵抗相关性的研究进展[J].医学综述,2012,18(20):3356-3358. 被引量:6

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部